
Plant-based medical treatments are gaining popularity, as consumers become increasingly more privy to their various health benefits. By 2030, the global botanical and plant-derived drug market is expected to reach $37.8 billion, at a compound annual growth rate (CAGR) of 3.5%. Yet, while its future looks promising, the industry still some roadblocks to overcome. This graphic by RYAH MedTech looks at the key issues the plant-based medical industry is facing, and how big data can help solve them. Learn More
Reference
https://www.visualcapitalist.com/big-data-and-plant-based-medicine/